baber/WOPTO huggingface dataset:
Patent NZ-544650-A (NZ)
Title: Information reproduction apparatus and method using audio repeat information
Inventor: TAKAKUWA NOBUYUKI
IPC: G11B20/10
Filed: 2004-06-02
Abstract: An information recording medium is disclosed, which has recorded thereon a plurality of sets of still image information to be continuously played back in a form called a slide show, and audio information is played back in synchronization with the still image information. Also recorded on the information recording medium is playback control information for playing back the audio information in synchronization with the sets of still image information. When the still image information sets are sequentially played back, the audio information is played back in synchronization with the still image information according to the playback control information. The playback control information includes audio repeat information for controlling the repetition of the audio information. The repeated playback of the audio information is controlled according to the audio repeat information.
Patent NZ-545256-A (NZ)
Title: Orbital sander with vertical handle
Inventor: COOPER VINCENT P
Filed: 2005-03-24
Abstract: A power driven oscillating tool 10, such as a random orbital sander, comprises a housing 12 having a longitudinal axis 13 situated centrally of the housing 12 for substantially its entire vertical extent. The housing 12 has an upper gripping surface 24, a motor 14 disposed in the housing 12, a carrier 18 disposed below the housing 12 which is driven to oscillate by the motor 14 and a side gripping surface 26 displaced from the housing 12 so as to form an open space between the gripping surface 26 and the housing 12. The side gripping surface 26 has a longitudinal axis which extends in generally the same direction as the longitudinal axis 13 of the housing 12. The tool 10 is configured to allow one-handed operation by gripping the upper or side gripping surface 24, 26.
Patent NZ-549070-A (NZ)
Title: Anti-infectious hydrogel compositions
Inventor: GRUENING RAINER
IPC: A61K47/36
Filed: 2005-02-18
Abstract: Disclosed is a fully reversible hydrogel composition comprising a poly(N-vinyllactam), a polysaccharide, and 25 wt% to 90 wt% water. Further disclosed are methods of applying the hydrogel to the body cavities of non-human mammals for inhibiting the intrusion of micro-organisms into the body.
Patent NZ-552406-A (NZ)
Title: Delivery system
Inventor: CUCA ROBERT C
IPC: A61K9/00
Filed: 2005-07-08
Abstract: A delivery system for a pharmaceutically active agent that consists of an emulsion of the pharmaceutically active agent and one or more pharmaceutically acceptable excipients. The delivery system allows the controlled release of the pharmaceutically active agent. The delivery system is characterised by having an internal to external phase ratio of more than 70% after it has been stored for at least a month at a temperature of 86°F.
Patent NZ-553844-A (NZ)
Title: Methods and systems for marking, tracking and authentication of products
Inventor: SAGER ALAIN
IPC: G06K17/00
Filed: 2005-09-29
Abstract: A method of marking manufactured items is disclosed. The method includes providing secret codes to a checking centre and to a production line for the manufactured items; generating an ID code for each manufactured item; digitally signing each ID code by means of a secret derived from the secret codes and known to the checking center; and marking each manufactured item with the signed ID code.
Patent NZ-554734-A (NZ)
Title: Methods, Assays And Compositions For Treating Retinol-Related Diseases
Inventor: WIDDER KENNETH
Filed: 2005-12-07
Abstract: Disclosed is the use of a first compound capable of modulating serum RBP or TTR levels or activity for the manufacture of a medicament for treating age-related macular degeneration or dystrophy wherein the medicament is formulated for systemic administration.
Patent NZ-572203-A (NZ)
Title: Anti siphon tank inlet
Inventor: WHOLEY RYAN
IPC: B60K15/04
Filed: 2007-03-28
Abstract: An anti-siphon fluid tank inlet assembly includes an inlet pipe (5) extending from a mounting structure (2) located at its proximal end, and a float valve assembly (7) disposed beyond the distal end of the inlet pipe (5) and including a float (6). A fixed obstruction is located within a housing (22) between the proximal end of the inlet pipe (5) and the float (6). The obstruction (21) blocks any line of sight from the opening at the proximal end of the inlet pipe (5) to the float (6). A flow path (23) is defined between the obstruction (21) and the housing wall to allow fluid flow to the float valve assembly (7) around the obstruction (21).
Patent NZ-573712-A (NZ)
Title: Bushing for use in an axle clamp for a vehicle suspension
Inventor: DUDDING ASHLEY THOMAS
IPC: B60G9/00
Filed: 2002-02-21
Abstract: An axle clamp assembly for use in a vehicle suspension assembly is disclosed. The axle clamp includes first and second axle clamps and a bushing. The first axle clamp assembly component is used to clamp the vehicle axle and the second axle clamp assembly component cooperates with the first axle clamp assembly component to clamp the vehicle axle, where the second axle clamp assembly component has a curved surface. The bushing has a bar pin adapted for installation within a bore extending through a suspension component to enable connection between the suspension component and the second axle clamp assembly component. The bar pin has a single flat surface over a portion of its perimeter at a bar pin end and a curved surface over a remainder of the perimeter at the bar pin end to define a D-shaped configuration. The curved surface of the bar pin is received within the curved surface of the second axle clamp assembly component. (62) Divided Out of 556036
Patent NZ-574659-A (NZ)
Title: Quality control of agricultural products based on gene expression
Inventor: VAN WORDRAGEN MONIQUE FRANCISCA
IPC: C12Q1/68
Filed: 2007-08-06
Abstract: A diagnostic method for determining a future quality trait stage or phenotype of a plant or mushroom that comprises the steps: (a) Providing a nucleic acid sample of a plant; (b) Analysing the nucleic acid sample by determining the expression level of at least two indicator mRNA transcripts in the sample, selected from a set of indicator mRNA transcripts which are indicative of a future quality trait stage; (c) Identifying and selecting the plants or mushrooms that comprise a certain expression profile of the indicator mRNA transcripts; and (d) Separating the plant or mushroom having different expression profiles of the indicator mRNA transcripts from one another. The plant can be from a family selected from the group consisting of Fagaceae, Maloideae, Rosoideae, Solanaceae, or the mushroom can be a basidiomycete. The future quality trait can be cold tolerance of tree seedlings, ripening of fruit, sensory decay of fruit, Botrytis. incidence or roses, discoloration development in mushrooms and firmness development in tomato.
Patent NZ-574824-A (NZ)
Title: Permutation data transform to enhance security
Inventor: DAMGAARD IVAN BJERRE
IPC: H04L9/34
Filed: 2005-08-09
Abstract: A data transformer, comprises: an input port to receive data including a plurality of bits; a divider to divide the data into a first segment and a second segment; a calculator to compute an exponential permutation of the data using the first segment, the second segment, and a predefined modulus; and an output port to output the first segment and the exponential permutation as transformed data. A data security device, comprises a data transformer as described above. The predefined modulus includes an implementation of a first formula to compute a power as a function of the first segment with the power being relatively prime to a function of the redefined modulus; an implementation of a second formula to compute a result of raising a function of the second segment to the power; and an implementation of a third formula to compute the exponential permutation as the result modulo. The data security device also has an implementation of a security algorithm to secure the transformed data.
Patent NZ-583207-A (NZ)
Title: Method for producing n-methacryloyl-4-cyano-3-trifluoromethylaniline
Inventor: KATSURA TADASHI
IPC: C07C253/30
Filed: 2008-09-02
Abstract: Disclosed is a method for producing N-methacryloyl-4-cyano-3-trifluoromethylaniline a raw material for the production of bicalutamide, wherein 4-cyano-3-trifluoromethylaniline is crystallized from a mixed solvent of methanol and water, and the obtained 4-cyano-3-trifluoromethylaniline is reacted with methacryloyl chloride.
Patent NZ-583522-A (NZ)
Title: Dough moulder safety guard for operator's hands
Inventor: WILLETT PAUL EATON
IPC: A23P1/00
Filed: 2010-02-24
Abstract: Disclosed is a dough moulder with a safety feature to protect an operator's hands. The dough moulder includes a housing for at least one pair of rollers (1) having an access opening (5) to the at least one pair of rollers. The access opening is provided with a guard arrangement (7) on which the operators arm rests during operation of the rollers. The dough moulder further includes a detector (6) having means to interrupt operation of the moulding rollers when the operator's hand is detected in a detector space.
Patent NZ-587201-A (NZ)
Title: Vaccines
Inventor: WALLER ANDREW STEPHEN
IPC: A61K39/09
Filed: 2009-01-20
Abstract: Disclosed is a Streptococcus vaccine strain comprising the following modifications in its genome: (i) attenuation of the aroB and pyrC genes or homologues thereof as specified in Table 7A, (ii) attenuation of one or more genes which encode a haemolytic toxin, or the sagA gene or a homologue thereof as specified in Table 7A, plus any one, two, or three of the following modifications: (iii) attenuation of one or more genes which encode a protein responsible for formation of a hyaluronate capsule, (iv) modification of the seM gene or a homologue thereof as specified in Table 7A to permit serological discrimination of the vaccine strain based on analysis of a protein encoded by said gene, and (v) attenuation of one or more genes which encode an enzyme responsible for recombination repair of the genome, wherein the Streptococcus vaccine strain is selected from any one of Streptococcus equi, Streptococcus zooepidemicus and Streptococcus pyogenes.
Patent NZ-587590-A (NZ)
Title: Novel 7-substituted derivatives of 3-carboxy-oxadiazino-quinolones, preparation thereof and use thereof as anti-bacterial agents
Inventor: CIAPETTI PAOLA
IPC: A61K31/5395
Filed: 2009-02-26
Abstract: The subject of the invention is 7-substituted 3-carboxy-oxadiazino-quinoline derivatives of formula(I) in which: either R1 represents: H, OH, NH2 , -(CH2)m - NRaRb in which m = 0, 1 or 2, Ra and Rb are identical or different and represent H, linear, branched or cyclic (C1-C6) alkyl, (C3-C6) cycloalkyl-(C1-C6)-alkyl; or also represent Rc, S(O)2Rc, C(O)Rc, S(O)2Rd or C(O)Rd; or Ra and Rb form together with the nitrogen atom, an Rc radical; Rc represents a saturated, unsaturated or aromatic 5- to 6-member ring containing 1 to 4 heteroatoms chosen from N, O and S, optionally substituted by 1 to 3 (C1-C6) alkyl radicals, said ring being linked, if appropriate, to the nitrogen atom of NRaRb by a nitrogen atom or a carbon atom; Rd represents a linear or branched (C1-C6) alkyl or (C3-C6) cyclic alkyl radical, optionally substituted by 1 to 4 halogens; or R1 represents Rc or CHReRc or CHReRd; Rc and Rd are as defined above, Re represents H, OH, NH2, NH-(C1-C6)-alk or N-(C1-C6)-alk2, or NH-(C1-C7)-acyl or NHRc, Rc being as defined above; R2 represents: H, (CH2)m-NRaRb, Rc, CHReRc or CHReRd, Ra, Rb, Rc, Rd and Re are as defined above; and R'2 represents H; it being understood that R1 and R2 cannot at the same time be H or that R1 and R2 or R2 and R1 cannot be one (CH2)m-NRaRb or Rc or H and the other one OH, or one H and the other one Rc or NH2, or one H and the other one (CH2)m-NRaRb in which Ra and Rb represent H or (C1-C6) alkyl or C(O)Rd, in which Rd represents an unsubstituted linear or branched (C1-C6) alkyl or (C3-C6) cyclic alkyl radical; - or R1 has the above definition except H and R2 and R'2 together represent gem (C1-C6) dialkyl or (C1-C6) alkyl-oxime, or R2 and R'2 represent respectively Rc or Rd and OH, NH2, NHRc or NHRf, Rc and Rd being as defined above and Rf being a (C1- C7) acyl radical; - or R1 represents H and R2 and R'2 together represent (C1-C6) alkyl-oxime or one represents Rc and the other one represents OH, NH2, NHRc or NHRf, Rc and Rf being defined as above; n is 0 or 1; R3 and R'3, identical or different, represent H or (C3-C6) alkyl optionally substituted by 1 to 3 halogens or R3 represents a (C1-C6) alkoxy carbonyl group and R'3 represents H; R4 represents methyl optionally substituted by one to three halogens; R5 represents H, (C1-C6) alkyl or (C7-C12) arylalkyl; R6 represents H, fluorine, NO2, CF3 or CN. And examples of which are: 8-fluoro-3-methyl-6-oxo-9-[3-(pyrazin-2-ylaminomethyl)-pyrrolidin-1-yl]-2,3-dihydro-6H-1-oxa-3,3a-diaza-phenalene-5-carboxylic acid and 9·{ 3-[di-pyrazin·2-yl·amino)·methyl]pyrrolidin-1·yl} S·fluoro-3-methyl- 6-oxo-2,3-dihydro-6H-l-oxa-3,3a-diaza-phenalene-5-carboxylic acid and 9-{ 3-[di-pyridin-2-yl-amino)-methyl]pyrrolidin-l-yl} S-fluoro-3-methyl-6-oxo-2.3-dihydro-6H-l-oxa-3,3a-diaza-phenalene-5-carboxylic acid
Patent NZ-590512-A (NZ)
Title: Use of plant growth regulators abscisic acid (aba) and cytokinin to reduce aba related plant leaf yellowing
Inventor: LIU XIAOZHONG
IPC: A01N35/02
Filed: 2009-07-23
Abstract: Discloses a method for decreasing abscisic acid (ABA) induced leaf yellowing in a plant comprising applying an effective amount of ABA and a cytokinin to a plant. The cytokinin is an adenine-type cytokinin (i.e. 6-benzylaminopurine ) or a phenylurea-type cytokinin (i.e. N1-(2-chloro-4-pyridyl)-N3-phenylurea).
Patent NZ-591102-A (NZ)
Title: Mould for manufacturing a composite part including at least one fibre reinforced matrix
Inventor: CHRISTIANSEN LARS FUGLSANG
IPC: B29C33/00
Filed: 2010-02-15
Abstract: A mould 1 for manufacturing a composite part including at least one fibre reinforced matrix in particular a wind turbine blade is provided. The mould 1 includes at least one thermal insulating core layer 2 disposed between at least one inner laminate layer 3 and at least one outer laminate layer 4 and at least one heating and/or cooling means 6 disposed in contact or in close proximity to the inner and/or outer laminate layer. The heating and/or cooling means 6 comprises at least one pipe for transporting a heating and/or cooling medium, and the mould 1 comprises at least one sensor 17 for determining the flow and/or heating power of the heating and/or cooling medium.
Patent NZ-595428-A (NZ)
Title: Improved glucocorticoid therapy
Inventor: LENNERNAS HANS
IPC: A61K31/573
Filed: 2010-04-07
Abstract: 595428 Disclosed is a composition produced from a system comprising: (i) 1.5 wt % to 6.5 wtl% of one or more glucocorticoids; (ii) 15 wt% to 25 wt % polymer or binder; (iii) 30 wt% to 40 wt% filler; (iv) 0.1 wt% to 0.5 wt% glidant; (v) 0.1 wt% to 0.5 wt% lubricant; (vi) 1 wt% to 5 wt% of film coating system; and (vii) 25 wt% to 40 wt% solvent, wherein the solvent is wholly or partially removed by evaporation after combining parts (i) to (vii), and wherein the ratio between a first immediate release part and a second extended release part is in range of 20-30% of the glucocorticoid for the coating (first part) of the total amount of glucocorticoid and 70-80% of the core (second part) of the total amount of glucocorticoid. Also disclosed is the use of the composition in the manufacture of a medicament for the treatment by glucocorticoid therapy in a subject with diminished or disrupted endogenous glucocorticoid secretory pattern so that one or more side effects of the glucocorticoid therapy were reduced; or; treating or preventing a diminished or disrupted endogenous glucorticoid secretory pattern in a subject with sufficient adrenal capacity.
Patent NZ-596157-A (NZ)
Title: Wood preservative formulations comprising an amine oxide an azole and an amine compound
Inventor: WARBURTON PAUL STUART
IPC: A01N33/04
Filed: 2007-05-24
Abstract: Disclosed herein is a wood preservative formulation comprising a synergistic combination of an amine oxide, an azole and a compound of formula (I), wherein said amine oxide is: a trialiphatic substituted amine oxide; an N-alkylated cyclic amine oxide; a dialkylpiperazine di-N-oxide; an alkyldi(poly(oxyalkylene))amine oxide a dialkylbenzylamine oxide; a fatty amidopropyl dimethyl amine oxide; a diamine oxide; a triamine oxide; or any combination of any of the foregoing; and wherein the azole is represented by the general formula (Z), where the substituents are as defined within the specification; with the exception of the following azoles: an imidazole selected from the group consisting of: benzimidazole, thiabendazole, imazalil, carbendazim, prochloraz; a 1,2,4-trazole selected from compounds of formula (XI), compounds of formula (XIII), wherein the substituents are as defined within the specification; or selected from the group comprising triadimefon, triadimenol, triazbutil, cyproconazole, difenoconazole, fluquinconazole, flusilazole, uniconazole, diniconazole, bitertanol, hexaconazole, flutriafol, epoxyconazole, tetraconazole, penconazole, and mixtures thereof or mixtures of both said imidazole and said 1,2,4-triazole.
Patent NZ-596174-A (NZ)
Title: Direct current plasma apparatus for forming a coating of a precursor material on a target
Inventor: MOHANTY PRAVANSU S
IPC: G21K5/00
Filed: 2010-05-03
Abstract: 596174 Disclosed is a direct current plasma apparatus (10). The apparatus (10) includes a housing (12) and a cathode (14) disposed in the housing. An annular channel (18) is generally disposed adjacent the cathode, and is configured to fluidly transmit a plasma gas (20). An anode (16) is positioned operably adjacent to the cathode (14) to permit electrical communication therebetween, sufficient to ignite a plasma jet (24) within the plasma gas (20). A precursor source (46) contains a precursor material (44) and a precursor outlet line which extends through at least a portion of the cathode (14). The precursor outlet line is terminated at an opening, which is offset from a tip of the cathode (14) to generally prevent deposition of the precursor material (44) at the tip of the cathode (14). The plasma jet (24) is capable of entraining, melting, and depositing at least some of the precursor materials (44) upon a target.
Patent NZ-598166-A (NZ)
Title: Methods, primers, probes and kits useful for the detection of braf mutations
Inventor: DANENBERG KATHLEEN
IPC: C12N15/11
Filed: 2010-08-10
Abstract: 598166 Disclosed is a method for detecting the presence of a BRAF mutation in a sample, said method comprising: (a) isolating a nucleic acid from said sample, wherein the sample is a formalin fixed paraffin-embedded (FFPE) tissue sample, and the sample comprises DNA sequences; (b) performing an amplification reaction of said DNA sequences of said sample, wherein said amplification reaction comprises a first primer capable of annealing specifically to a BRAF mutant sequence at a first position in a BRAF DNA sequence, wherein said first primer comprises AAAAATAGGTGATTTTGGTCTAGCTACATA, AATAGGTGATTTTGGTCTAGCTACTGA, AGGTGATTTTGGTCTAGCTACTGC, AATAGGTGATTTTGGTCTAGCTACAAAT, AAAATAGGTGATTTTGGTCTAGCTACTAA, AAAATAGGTGATTTTGGTCTAGCTAGAA, AAATAGGTGATTTTGGTCTAGCTACATAT, AAAATAGGTGATTTTGGTCTAGCTACTAT or AATAGGTGATTTTGGTCTAGCTACACAG and a second primer capable of annealing specifically at a second position in a BRAF DNA sequence, wherein said first and second primers anneal to different strands of double stranded BRAF DNA sequence, wherein the amplification reaction is capable of producing a BRAF mutant specific amplification product when the DNA sequences of the sample comprise a BRAF DNA sequence comprising a mutant sequence at said first position of said BRAF DNA sequence; and (c) visualizing amplification products produced by said amplification reaction, wherein detection of a BRAF mutant specific amplification product is a positive indicator of a BRAF mutation in said sample.
Patent NZ-598924-A (NZ)
Title: Compounds comprising pyrimidyl and pyrazolyl moieties and compositions as protein kinase inhibitors
Inventor: HUANG SHENLIN
IPC: A61K31/506
Filed: 2010-08-27
Abstract: Disclosed are compounds of Formula (Ia), salts thereof and methods for their preparation. Specific examples of compounds of Formula (Ia) include: methyl N-[(2S)-1-({ 4-[3-(3-chloro-5-methanesulfonamidophenyl)-1-(propan-2-yl)-1H-pyrazol-4-yl]pyrimidin-2-yl} amino)propan-2-yl] carbamate, methyl N-[(2S)-1-{ [4-(3-{ 2-fluoro-3-[(3,3,3-trifluoropropane)sulfonamido]phenyl} -1-(propan-2-yl)-1H-pyrazol-4-yl)pyrimidin-2-yl]amino} propan-2-yl] carbamate, N-[5-chloro-3-(4-{ 2-[(2-cyanoethyl)amino]pyrimidin-4-yl} -1-(propan-2-yl)-1H-pyrazol-3-yl)-2-fluorophenyl]methanesulfonamide, and methyl N-[(2S)-I-( { 4-[3-(S-chloro-2-fluoro-3-methanesulfonamidophenyl)-1-(propan-2-yl)-1H-pyrazol-4-yl]pyrimidin-2-yl} amino)propan-2-yl]carbamate. Compounds of formula Ia are useful for treating diseases or disorders associated with abnormal or deregulated kinase activity, particularly diseases of disorders that inveolve abnormal activation of B-Raf. Examples of diseases include lung carcinoma, pancreatic carcinoma, bladder carcinoma, colon carcinoma, and myeloid disorders, prostate cancer, thyroid cancer, melanoma, adenomas and carcinomas of the ovary, eye, liver, biliary tract, and nervous system.
Patent NZ-599425-A (NZ)
Title: Knife block and sharpener
Inventor: MURPHY ROSEMARY
IPC: A47G21/14
Filed: 2010-10-15
Abstract: 599425 A device such as a knife block for containing one or more blades (26) is disclosed. Each of the blades include an opening (35) within the blade. The device includes a housing having a plurality of openings for containing a respective blade and a blade restraining mechanism (60). When a blade (26) is inserted in one of the openings the restraining member (56a-e), in an active condition, prevents engages with the opening (35) withdrawal of the blade (26). In a further embodiment the knife block may also include a blade sharpener.
Patent NZ-605433-A (NZ)
Title: System for monitoring electrical power usage of a structure and method of same
Inventor: YOGEESWARAN KARTHIK
IPC: G01R21/06
Filed: 2011-07-01
Abstract: Disclosed is a system (100) for monitoring usage of electrical power by a structure, the structure having one or more main electrical power lines that supply the electrical power to a first load in the structure. A portion of the one or more main electrical power lines (193, 194, 195) runs substantially parallel to a first axis. The structure further has a panel (190), such as the cover of a circuit breaker box, that overlies the portion of the one or more main electrical power lines (193, 194, 195). The system (100) comprises a current sensor unit (110) and a processing unit (120). The current sensor unit (110) is configured to be coupled to a portion of a surface of the panel (190) and includes at least one magnetic field sensor having a length substantially parallel to a second axis, wherein the second axis is substantially perpendicular to the first axis. The at least one magnetic field sensor is configured to detect a magnetic field generated by the one or more main electrical power lines (193, 194, 195). The processing unit (120) is configured to run on a processor. The current sensor unit (110) is configured to produce an output signal based on the magnetic field detected by the at least one magnetic field sensor. The processing unit (120) is further configured to receive the output signal from the current sensor unit (110) and process the output signal to determine one or more parameters related to the usage of the electrical power by the first load in the structure.